Guidance Capital, Inc Neogenomics Inc Transaction History
Guidance Capital, Inc
- $327 Billion
- Q4 2024
A detailed history of Guidance Capital, Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Guidance Capital, Inc holds 32,030 shares of NEO stock, worth $458,029. This represents 0.15% of its overall portfolio holdings.
Number of Shares
32,030Holding current value
$458,029% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding NEO
# of Institutions
293Shares Held
125MCall Options Held
698KPut Options Held
116K-
Black Rock Inc. New York, NY19.7MShares$281 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$201 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$98.5 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$94.4 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$93.5 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.8B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...